Literature DB >> 3013800

Therapeutic trials of multiple sclerosis and intrathecal IgG production.

M Wender, E Tokarz, G Michalowska, A Wajgt.   

Abstract

In our clinical trial we have compared the effect of high doses of prednisone, ACTH alone or ACTH and cyclophosphamide on plasma and CSF albumin and IgG levels. We have found that the treatment with high doses of prednisone is more effective in the suppression of CNS IgG synthesis than ACTH, or cyclophosphamide. However the significance of this immunological phenomenon in the pathogenesis of MS is a very complex problem, since we have not observed any correlation between the depression of the intrathecal IgG synthesis and clinical results of MS treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013800     DOI: 10.1007/bf02230883

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  1 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09
  1 in total
  2 in total

1.  Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.

Authors:  Daniel M Harrison; Douglas E Gladstone; Edward Hammond; Jeffrey Cheng; Richard J Jones; Robert A Brodsky; Douglas Kerr; Justin C McArthur; Adam Kaplin
Journal:  Mult Scler       Date:  2011-08-24       Impact factor: 6.312

Review 2.  Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.

Authors:  Mickael Bonnan
Journal:  Mult Scler Int       Date:  2015-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.